This NDC is on FDA's drug shortage list (posted Dec 22, 2021)
Reported reason: Shortage of an active ingredient
Product Information
RIFAMPIN 300 MG CAPSULE is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.6802 per EA under NDC 68180065907. Its NADAC has been published 657 times since Jan 22, 2014.
FDA first approved this application on Aug 21, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180065907
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RIFAMPINApproval Type
Generic (ANDA)
FDA Application
ANDA090034FDA Approved
8/21/2013
TE Code
AB
On Market Since
1/8/2014
Pharmacological Classes
Price Statistics
The NADAC for RIFAMPIN 300 MG CAPSULE has been published 657 times since Jan 22, 2014, and over the history we have for it it has declined 35.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6802 per EA |
|---|---|
| All-time high | $1.2801 (Aug 13, 2014) |
| All-time low | $0.4888 (Nov 20, 2024) |
| 52-week high | $0.7186 |
| 52-week low | $0.6802 |
| Median price | $0.7108 |
| Average price | $0.7559 |
| Largest weekly change | -29.8% (Apr 20, 2022) |
| Weeks tracked | 657 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RIFAMPIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIFAMPIN 300 MG CAPSULE, manufactured by Lupin Pharmaceuticals Inc., is $0.6802 per EA (NDC 68180065907), effective Aug 19, 2026.
How has the price of RIFAMPIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIFAMPIN 300 MG CAPSULE has declined 35.9%. It has been tracked across 657 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for RIFAMPIN 300 MG CAPSULE?
Since Jan 22, 2014, the NADAC for RIFAMPIN 300 MG CAPSULE has ranged from a low of $0.4888 (Nov 20, 2024) to a high of $1.2801 (Aug 13, 2014), with a median of $0.7108 per EA.
Are there cheaper alternatives to RIFAMPIN 300 MG CAPSULE?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RIFAMPIN 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures RIFAMPIN 300 MG CAPSULE?
RIFAMPIN 300 MG CAPSULE (NDC 68180065907) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Is RIFAMPIN 300 MG CAPSULE in shortage?
Yes — NDC 68180065907 is currently listed in FDA's drug shortage database (posted Dec 22, 2021). Reported reason: Shortage of an active ingredient.